Epidemiology of Inhibitors in Haemophilia A
- 1 February 1996
- journal article
- Published by Wiley in Vox Sanguinis
- Vol. 70 (s1) , 2-8
- https://doi.org/10.1111/j.1423-0410.1996.tb01341.x
Abstract
One of the most serious complications of the treatment of haemophilia A is the development of inhibitors. Former studies mostly considered the prevalence of inhibitor development, thus underestimating its true risk. Prevalences ranged widely (7–18%) probably due to the populations studied and the study design. Recent prospective previously untreated patients (PUP) studies were more comparable because of similar study designs. Eight PUP studies regarding the incidence of factor VIII inhibitors were analyzed: The inhibitor incidences (Independent of severity of haemophilia) ranged from 18.4 to 28%. Evaluating only severe haemophiliacs (factor VIII<2%) significantly higher incidences were found. After 9–36 exposure days (as medians inhibitor development occurred at 0.8‐3.3 years of age (as medians).Keywords
This publication has 10 references indexed in Scilit:
- Incidence of Factor VIII Inhibitor Development in Hemophilia A Patients Treated with Less Pure Plasma Derived ConcentratesThrombosis and Haemostasis, 1994
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A -- Safety, Efficacy, and Development of InhibitorsNew England Journal of Medicine, 1993
- Prevalence of Inhibitors in a Population of 3435 Hemophilia Patients in FranceThrombosis and Haemostasis, 1992
- Factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Viral safety and inhibitor development associated with monoclonal antibody-purified F VIII CAnnals of Hematology, 1991
- Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcomeBritish Journal of Haematology, 1990
- The natural history of factor VIII:C inhibitors in patients with hemophilia A: a national cooperative study. II. Observations on the initial development of factor VIII:C inhibitorsBlood, 1988
- Incidence of inhibitors in patients with severe and moderate hemophilia a treated with factor VIII concentratesAmerican Journal of Hematology, 1987